Can-Fite Reports Positive Phase 2a Data For Pancreatic Cancer Drug
30/4 16:20
(RTTNews) - Thursday, Can-Fite BioPharma Ltd. (CANF) announced encouraging results from its Phase 2a clinical trial for namodenoson, a drug aimed at treating advanced pancreatic cancer....
